Indiana Homecare Enteral Feeding Formula Market Size [2031]

Report Description

Indiana Homecare Enteral Feeding Formula Market Outlook 2031

The Indiana homecare enteral feeding formula market size was USD 81.95 Mn in 2022 and is likely to reach USD 157.1 Mn by 2031, expanding at a CAGR of 7.5% during 2023–2031. The market growth is attributed to the rising preference for home-based care and increasing demand for specialized formulas for specific medical conditions.

Advancements in medical technology are anticipated to significantly boost the market. Rising aging population with health conditions that lead to difficulty in swallowing require enteral feeding for nutritional support.

Get Free Sample Report

Homecare enteral feeding formula refers to a specialized type of nutritional formula designed for enteral feeding. Enteral feeding involves delivering a nutritionally complete liquid formula directly into the gastrointestinal tract through a feeding tube. This method is used when a person is unable to consume food orally or has difficulty absorbing nutrients from regular food.

The market report finds that the COVID-19 pandemic hampered the Indiana homecare enteral feeding formula market. The pandemic disrupted global supply chains, which affected the production and distribution of various medical supplies, including enteral feeding formulas. This led to temporary shortages or delays in obtaining specific formulas.

During and post-pandemic, hospitals and healthcare facilities have registered an increased demand for enteral feeding products, due to the influx of patients, with some of them requiring specialized nutrition support.

Impact of Artificial Intelligence (AI) on Indiana Homecare Enteral Feeding Formula Market

Artificial Intelligence (AI) is expected to boost the revenue of the players in the Indiana homecare enteral feeding formula market. This technology plays a pivotal role in the market, as it analyzes a patient's medical history, dietary preferences, and nutritional requirements to create highly personalized enteral feeding plans.

AI-powered tools help in optimizing the supply chain for enteral feeding formulas. This includes inventory management, and distribution logistics while ensuring that products are readily available for patients.

Indiana Homecare Enteral Feeding Formula Market Dynamics

Get Free Sample Report

Major Drivers

Rising prevalence of chronic disease drives the market. Chronic diseases such as cancer, diabetes, gastrointestinal disorders, and neurodegenerative conditions are becoming prevalent.

These conditions often lead to complications that affect an individual's ability to absorb or swallow nutrients through regular oral intake. Enteral feeding formulas are designed to deliver specific nutrients in a form that is easily absorbed by the digestive system, which makes them essential for individuals with chronic conditions. For instance,

• As per the data published by the American Cancer Society, around 1.9 million individuals were diagnosed with cancer in 2021 and approximately 608,570 cancer deaths occurred only in the US alone.

Existing Restraints

Increasing patient safety concerns hampers the market. Feeding and medication errors lead to serious health risks for patients. Administering the wrong type or amount of enteral feeding formula, or mixing up medications results in complications, adverse reactions, and even life-threatening situations.

Emerging Opportunities

Technological advancements create lucrative opportunities in the market. Technological advancements enable remote patient monitoring for receiving enteral feeding at home. This facilitates improved oversight by healthcare providers, which leads to timely interventions, if any issues arise. Additionally, telehealth integration provides patients with access to real-time support and guidance.

Scope of the Indiana Homecare Enteral Feeding Formula Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Indiana Homecare Enteral Feeding Formula Market Segment Insights

Product Segment Analysis

Based on product, the Indiana homecare enteral feeding formula market is divided into disease-specific formula, blenderized formula, and standard formula. The standard formula segment is expected to hold a dominant share of the market during the projection period, due to the widespread use of enteral feed for fundamental clinical nutrition supplementation.

Standard enteral feeding formulas serve as a major source of clinical nutrition supplementation. They are designed to meet the general nutritional needs of a wide range of patients. This broad applicability leads to their widespread use and makes it easily accessible for healthcare providers to acquire and administer these formulas to patients, further boosting their prevalence and, thus, the market.

The disease-specific formula segment is expected to expand at a significant pace in the coming years, as it provides targeted nutrition and reduces the risk of complications. Disease-specific formulas are specifically designed to meet the unique nutritional requirements of patients with specific medical conditions.

These specialized formulations provide essential nutritional support to patients with specific diseases linked to organ dysfunctions. Patients with chronic conditions require formulas that are carefully formulated to manage their specific health concerns. Disease-specific formulas reduce the risk of complications and improve overall health outcomes.

Get Free Sample Report

Flow Type Segment Analysis

On the basis of flow type, the global market is segregated into continuous and intermittent. The intermittent feeding flow segment is projected to expand at a high CAGR during the forecast period, as it enhances patient mobility and improves physiological efficiency.

Intermittent feeding allows patients to have free periods of time when they are not tethered to a feeding tube, which increases their mobility and overall quality of life. It is aligned with natural physiological processes, as it mimics regular eating patterns. This supports gut homeostasis and aids in efficient digestion and absorption of nutrients, which improves patient outcomes.

The continuous segment is expected to expand at a significant pace in the coming years, as it provides consistent nutrient delivery and is suitable for patients with high nutritional requirements. Continuous feeding ensures a consistent delivery of nutrients to the patient's gastrointestinal tract over an extended period. This is important for individuals who have difficulty tolerating large volumes of formula at one time. Continuous feeding reduces the risk of gastrointestinal disturbances, such as reflux or diarrhea, which occur with intermittent feeding methods.

Stage Segment Analysis

On the basis of stage, the Indiana homecare enteral feeding formula market is segmented into adults, geriatric, and pediatric. The adult segment is anticipated to expand at a robust growth rate during the forecast period, due to the growing aging population and chronic disease management.

Adults are susceptible to health issues that impair their ability to eat and absorb nutrients orally. Adults, particularly those in old age groups, who experience chronic health conditions, such as diabetes, renal failure, or heart disease, benefit from disease-specific enteral feeding formulas that are tailored to their specific medical conditions.

Get Free Sample Report

Indication Segment Analysis

Based on indication, the Indiana homecare enteral feeding formula market is divided into Alzheimer’s, nutrition deficiency, diabetes, cancer, chronic kidney disease, dysphagia, orphan disease, pain management, and malabsorption/diarrhea. The cancer segment is expected to generate a major revenue share of the market, due to the high prevalence of cancer cases and nutritional challenges faced by patients.

Rising prevalence of cancer is estimated to drive the segment. Many cancer patients experience difficulty eating or have specific dietary requirements, due to their treatment and condition. Cancer and its treatments lead to a range of nutritional challenges, including loss of appetite, difficulty swallowing, nausea, and changes in taste and smell perception. Manufacturers are developing enteral feeding formulas that are tailored to address these specific nutritional needs. For instance

• In December 2020, Abbott broadened its Pedialyte product line by introducing four formulations for bolstering the immune system. These include Pedialyte with immune support, Pedialyte Sport, Pedialyte Organic, and Pedialyte Electrolyte Water with zero sugar.

The orphan disease segment is anticipated to gain a significant revenue share, as it requires specialized nutritional needs and limited treatment options. Orphan diseases often come with unique and complex nutritional requirements.

These conditions affect the digestive system, metabolism, or nutrient absorption, which necessitates specialized enteral feeding formulas to meet the specific needs of patients. Orphan diseases have limited treatment options available. Enteral feeding ensures they receive the necessary nutrients when conventional dietary approaches are insufficient.